Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
184.00
-4.50 (-2.39%)
At close: Dec 4, 2025
6.67%
Market Cap 15.07B
Revenue (ttm) 1.78B
Net Income (ttm) 268.63M
Shares Out 81.00M
EPS (ttm) 4.37
PE Ratio 42.57
Forward PE 35.36
Dividend 5.49 (2.98%)
Ex-Dividend Date Nov 24, 2025
Volume 203,418
Average Volume 296,513
Open 190.00
Previous Close 188.50
Day's Range 183.00 - 190.00
52-Week Range 146.50 - 401.00
Beta n/a
RSI 49.62
Earnings Date Nov 12, 2025

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd. [Read more]

Industry Pharmaceutical Preparations
Employees 20
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2024, Daiken Biomedical's revenue was 1.36 billion, an increase of 14.45% compared to the previous year's 1.19 billion. Earnings were 106.58 million, a decrease of -33.54%.

Financial Statements

News

There is no news available yet.